secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0000950170-23-067777
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kezar receives Nasdaq deficiency notice for bid price below $1.00
-----------------------------------------------------------------

- Received Nasdaq letter Dec 1, 2023; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 days, until May 29, 2024, to regain compliance.
- Must close at $1.00+ for 10 consecutive business days to cure.
- May qualify for additional 180-day period if transferred to Nasdaq Capital Market.
- Company will monitor bid price and evaluate options, including reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017023067777/0000950170-23-067777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017023067777/kzr-20231201.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-067777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer